Samrat Pharmachem Limited
BSE: SAMRATPH.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- CEO
- Lalit Damodar Mehta
- Employees
- 32
- Headquarters
- Mumbai, India
- IPO year
- 2002
- Market cap
- ₹664.1M
- Website
- http://www.samratpharmachem.com
Loading SAMRATPH…
Loading profile data…Frequently asked questions about SAMRATPH
What does Samrat Pharmachem Limited (SAMRATPH.BO) do?
Samrat Pharmachem Ltd. engages in the manufacturing manufacturing and selling chemicals. Its products include 3-5–Di iodosalicylic acid, aluminium iodide, clioquinol, ethylenediamine dihydroiodide, copper iodine, and lithium iodide. The company was founded by Lalit Damodar Mehta on June 16, 1992, and is headquartered in Mumbai, India.
Where does SAMRATPH.BO trade?
Samrat Pharmachem Limited (SAMRATPH.BO) trades on the Bombay Stock Exchange.
What sector is SAMRATPH.BO in?
Samrat Pharmachem Limited (SAMRATPH.BO) operates in the Basic Materials sector, specifically in the Chemicals - Specialty industry.
Who is the CEO of Samrat Pharmachem Limited?
Lalit Damodar Mehta is the chief executive officer of Samrat Pharmachem Limited (SAMRATPH.BO).
Where is Samrat Pharmachem Limited headquartered?
Samrat Pharmachem Limited is headquartered in India.
Does SAMRATPH.BO pay a dividend?
Yes — Samrat Pharmachem Limited (SAMRATPH.BO) paid a trailing twelve-month dividend of INR 1.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SAMRATPH.BO go public?
Samrat Pharmachem Limited (SAMRATPH.BO) completed its initial public offering in 2002.